<DOC>
	<DOCNO>NCT02529774</DOCNO>
	<brief_summary>This adaptive seamless Phase II/III trial compare efficacy safety adjuvant systemic chemotherapy ( SCT ) without hepatic arterial infusion ( HAI ) complete hepatic resection Chinese patient metastatic colorectal cancer .</brief_summary>
	<brief_title>Alternating Systemic Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection Liver Metastases From Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Diagnosis Criteria : All patient histologically confirm colorectal adenocarcinoma hepatic metastasis primary tumour completely resect operation colorectal metastatic liver confirm pathologically operation well negative surgical margin . Main criteria inclusion : Aged 1875 year Diagnosed colorectal adenocarcinoma spread liver extrahepatic metastasis Prior curative resection primary tumour ( R0 resection ) concurrent feasible curative resection primary tumour hepatic metastasis ( R0 resection meet ) Performance status ECOG 01 No serious complication occur metastasis resection affect subsequent treatment . Hematology : White blood count ≧ 4.0X10^9/L , Absolute neutrophil count ≧1.5X10^9/L , Platelet count ≧ 100 X10^9/L , Hemoglobin ≧ 100g/L Blood biochemistry : Total bilirubin ≦2mg/dL , Direct bilirubin equal less 1.5 time upper limit normal ( ULN ) , Alanine aminotransferase ( ALT ) great 2.5 time ULN , Aspartate aminotransferase ( AST ) great 2.5 time ULN , Serum creatinine great ULN , glomerular filtration rate equal great 60 mL/min/1.73m^2 Not pregnant nursing present Fertile patient must use effective contraception Able withstand major operative procedure No prior concurrent malignancy within past 5 year except basal cell squamous cell skin cancer carcinoma situ organ No prior hepatic artery infusion therapy 5FU floxuridine No prior systemic chemotherapy metastatic disease No concurrent chemotherapy Able understand sign inform consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>